Oncology & Cancer

Genomic tug of war could boost cancer therapy

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant ...

Oncology & Cancer

Health: Breast cancer in men

Breast cancer may be thought of as a disease that affects only women. It's the second-most common cancer diagnosed in women in the U.S., and it will affect one in eight women, according to the American Cancer Society. Much ...

Diseases, Conditions, Syndromes

Researchers uncover mechanism for treating dangerous liver condition

A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved ...

Diseases, Conditions, Syndromes

More screening vigilance needed to fight chronic liver disease: Study

A new study by QIMR Berghofer published in the Medical Journal of Australia has highlighted the critical need for doctors to be more vigilant with early detection and monitoring of liver complications in patients with diabetes ...

Oncology & Cancer

Four novel receptors may link endometrial cancer to PCOS

A new research paper titled "Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas has been published in Oncotarget.

Oncology & Cancer

New gene markers detect Lynch syndrome-associated colorectal cancer

Researchers from Mayo Clinic Comprehensive Cancer Center and Mayo Clinic Center for Individualized Medicine have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy. Studies ...

page 2 from 26